Equity Overview
Price & Market Data
Price: $15.00
Daily Change: -$0.25 / 1.67%
Daily Range: $14.56 - $15.31
Market Cap: $2,450,025,472
Daily Volume: 1,761,310
Performance Metrics
1 Week: -7.00%
1 Month: -14.97%
3 Months: -29.01%
6 Months: 24.31%
1 Year: 6.36%
YTD: -23.93%
Company Details
Employees: 191
Sector: Health technology
Industry: Biotechnology
Country:
Details
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.